DRC Awarded $11M Contract With National Institutes of Health
Dynamics Research Corporation (Nasdaq: DRCO), a leading technology and management consulting company focused on driving performance, process and results for government clients, today announced that it's been awarded with a new task order under the Chief Information Officer—Solutions and Partners 3 contract to provide technology, management, and evaluation services to the National Institutes of Health (NIH). The contract, including all periods and options, is valued at $11.4 million and has a 5-year period of performance.
Under the terms of the contract, DRC will provide independent verification and validation expertise to support the NIH IT enterprise system project managers in their efforts to maximize their IT investments. The technical services provided will include assisting the NIH enterprise system and projects in risk management and promoting use of best-in-breed technical approaches.
"The rigorous evaluation of enterprise IT systems and processes is critical for enabling agencies like the NIH to maximize their technology investments and uncover new ways to strategically leverage technology for improved mission outcomes," said Jim Regan, DRC's chairman and chief executive officer. "With this task order, our first task order under the CIO-SP3 contract, we will extend our technology expertise, management consulting insight and healthcare domain experience in support of this new customer."
About Dynamics Research Corporation
Dynamics Research Corporation (DRC) provides technology and management consulting solutions focused on driving performance, process and results for government clients. DRC offers innovative solutions and delivers rock solid results. DRC has large company capabilities and small company agility. Founded in 1955, DRC is a publicly held corporation (Nasdaq: DRCO) and maintains more than 25 offices nationwide with major offices in Andover, Massachusetts and the Washington, D.C. region. For more information please visit our website at www.drc.com.
Certain statements contained in this news release, which are not historical facts or are related to future plans, events, revenues and earnings expectations, objectives and outlooks are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and, by their nature, are uncertain and subject to a number of risks and uncertainties that could adversely affect the Company's results. We can provide no assurance that these statements will prove to be correct. Consequently, actual results could materially differ from these statements. For more detailed information concerning how these risks and uncertainties could affect the Company's financial results, please refer to DRC's most recent forms 10-K and 10-Q and other documents filed with the Securities and Exchange Commission. Further, the Company is under no duty or obligation to update or revise any forward looking statements as a result of events or new information.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.